VENTYX STOCK ANNOUNCEMENT: Ventyx (Nasdaq: VTYX) Shareholders are

VENTYX STOCK ANNOUNCEMENT: Ventyx (Nasdaq: VTYX) Shareholders are

NEW YORK, June 15, 2024 (GLOBE NEWSWIRE) — If you are a Ventyx Biosciences (NASDAQ: VTYX) shareholder, we encourage you to submit your information at

Why is Ventyx being investigated by the BFA?

A company’s directors and officers have fiduciary duties to the corporation and its shareholders. Bleichmar Fonti & Auld LLP is investigating whether Ventyx’s directors breached these fiduciary duties and/or committed other violations of securities laws.

Shareholders are encouraged to submit their data to learn about their rights.

Submit your details here:

What can you do?

If you are a shareholder of Ventyx Biosciences, Inc., you may have legal options available to you. All representation is paid on a contingency fee basis, there is no cost to you. Shareholders do not bear any court costs or expenses related to legal proceedings. The company will ask the court for permission to cover any potential fees and expenses.

To speak to a lawyer and get more information, visit:

Or contact:
Ross Shikowitz
[email protected]

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder disputes. In 2023, ISS SCAS named it a Top Five Plaintiff Law Firm, and its attorneys were recognized as Titans of the Plaintiffs’ Bar by Law360 and as SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million from Tesla, Inc. management. (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.

More information about BFA and its attorneys can be found at

Lawyer advertising. Past performance does not guarantee future results.